在COVID-19患者中查尔森并发症指数的预后值
Iliyan Todorov1, Margarita Gospodinova1, Kalina Stoyanova1
1Department of Infectious Diseases, Parasitology and Dermatovenerology, Faculty of Medicine, Medical University of Varna, 9002 Varna, Bulgaria.
Tropical medicine and infectious disease
|February 26, 2026
概括
查尔森并发症指数 (CCI) 预测慢性病患者的COVID-19严重结果. 较高的CCI得分与死亡率和疾病严重程度的增加相关,有助于早期风险识别.
科学领域:
- 传染性疾病 传染性疾病
- 流行病学 流行病学
- 老年学是指老年学的学科.
背景情况:
- COVID-19 (SARS-CoV-2) 呈现变化,严重病例通常发生在具有先前存在的慢性疾病的个体中.
- 查尔森并发症指数 (CCI) 是一种基于并发症预测死亡风险的工具.
研究的目的:
- 评估查尔森并发症指数 (CCI) 对COVID-19严重程度和并发症住院患者的预后价值.
主要方法:
- 558名住院COVID-19患者的回顾性分析 (2020年3月 - 2021年3月).
- 计算CCI得分以估计10年生存概率.
- 对CCI,并发病,疾病严重程度和死亡率之间的相关性进行统计分析.
主要成果:
- 较高的并发症数与双边肺结合,需要氧气治疗和死亡率增加相关 (p < 0.05).
- 较高的CCI得分与较差的患者结局有关.
- 在没有幸存者和患有严重呼吸道并发症的患者中,CCI分数高于5很普遍.
结论:
- 高龄和多种并发症是COVID-19预后不佳的重要预测因素.
- 在入院时早期的CCI计算可以识别高风险患者,以便及时进行干预.
相关概念视频
Pneumonia III: Complications and Assessment
977
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
977
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
3.2K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
3.2K
COPD: Pathogenesis and Clinical Features
2.0K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
2.0K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
3.9K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.9K
Acute Coronary Syndrome III: Diagnostic Studies
334
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
334
Chronic Obstructive Pulmonary Disease-V: Management
3.3K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.3K

